Canada has a lack of transparency about Big Pharma’s payments to health-care providers and organizations. Disclosure is voluntary, and there’s no central data on even the few companies that do report.
Articles on Pharmaceutical ethics
Displaying all articles
Patients have a stake in the relationship between doctors and pharmaceutical companies, so the CMA’s current review of its guidelines for doctor/pharma interactions is everybody’s business.
The pharmaceutical waste from Buffalo City dump sites reveals that the sale of over-the-counter drugs remains vastly unregulated and under-researched.
Sedatives contributed to a pharmaceutical revolution in South Africa in the divided 1950s, especially among white users.
From colonial poppy fields to pharmatrash, southern Africa offers a fascinating history of drug regimes – one that helps us make sense of drug policies and legislation today.
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
The HIV prevention drug Truvada (PrEP) will be listed on the Pharmaceutical Benefits Scheme from this Sunday, moving Australia closer to achieving its goal of ending new HIV transmissions by 2020.
Congress has sent a bill to the White House. It gives terminally-ill patients more false hope than chances for a cure.
Holding patents can be a lucrative and powerful position to be in. Here’s a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
Thalidomide’s manufacturer, Chemie Grünenthal, marketed the drug as safe for pregnant women despite reports it was causing malformations in newborns. Why such blatant denial?
Top contributors
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Research associate, University of Pretoria
-
Director, AIDS and Society Research Unit, University of Cape Town
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Associate Professor and Course Leader: Post Graduate Programmes in Clinical Pharmacy in the Department of Pharmacy, Sefako Makgatho Health Sciences University
-
Assistant Professor, Sociology, University of Victoria
-
Associate Professor, Monash University
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Professor of History, University of Johannesburg
-
Associate professor, School of Public Policy and Administration, Carleton University
-
Assistant Professor (Status), University of Toronto
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Research Fellow, American University School of Public Affairs
-
Professor of Law, Indiana University